ProQR Therapeutics (PRQR) Short Interest Ratio & Short Volume → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free PRQR Stock Alerts $1.98 -0.02 (-1.00%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ProQR Therapeutics Short Interest DataCurrent Short Volume215,300 sharesPrevious Short Volume241,500 sharesChange Vs. Previous Month-10.85%Dollar Volume Sold Short$417,682.00Short Interest Ratio / Days to Cover1.1Last Record DateApril 30, 2024Outstanding Shares81,360,000 sharesFloat Size51,890,000 sharesShort Percent of Float0.41%Today's Trading Volume181,123 sharesAverage Trading Volume149,160 sharesToday's Volume Vs. Average121% Short Selling ProQR Therapeutics ? Sign up to receive the latest short interest report for ProQR Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPRQR Short Interest Over TimePRQR Days to Cover Over TimePRQR Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide ProQR Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024215,300 shares $417,682.00 -10.9%0.4%1.1 $1.94 4/15/2024241,500 shares $493,867.50 -7.5%0.5%1.2 $2.05 3/31/2024261,100 shares $597,892.89 -4.0%0.5%0.9 $2.29 3/15/2024272,100 shares $696,576.00 +3.1%0.5%0.9 $2.56 2/29/2024263,900 shares $533,078.00 -17.3%0.6%0.9 $2.02 2/15/2024319,000 shares $622,050.00 +5.9%0.7%1 $1.95 Get the Latest News and Ratings for PRQR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024301,300 shares $653,821.00 -39.1%0.6%0.9 $2.17 1/15/2024494,800 shares $1.10 million -27.3%1.0%1.6 $2.23 12/31/2023680,400 shares $1.35 million -30.7%1.4%3.3 $1.98 12/15/2023981,100 shares $2.11 million +55.8%2.0%4.3 $2.15 11/30/2023629,800 shares $976,190.00 +2.6%1.3%2.9 $1.55 11/15/2023613,600 shares $908,128.00 -9.0%1.2%3.5 $1.48 10/31/2023674,200 shares $775,330.00 -4.5%1.4%3.8 $1.15 10/15/2023705,800 shares $868,134.00 +2.9%1.4%3.7 $1.23 9/30/2023685,900 shares $891,670.00 -24.4%1.4%3.3 $1.30 9/15/2023907,500 shares $1.46 million -3.6%1.8%4.7 $1.61 8/31/2023940,900 shares $1.51 million -2.9%1.7%3.9 $1.61 8/15/2023969,400 shares $1.49 million -16.4%1.8%3.5 $1.54 7/31/20231,160,000 shares $1.74 million +148.1%2.1%3.6 $1.50 7/15/2023467,600 shares $818,300.00 -2.9%0.9%1.3 $1.75 6/30/2023481,300 shares $779,706.00 -8.4%0.9%1.2 $1.62 6/15/2023525,200 shares $892,840.00 -34.0%0.9%0.8 $1.70 5/31/2023796,200 shares $1.39 million -41.9%1.4%1 $1.74 5/15/20231,370,000 shares $2.63 million -33.5%2.5%1.6 $1.92 4/30/20232,060,000 shares $4.49 million -20.2%3.7%2.3 $2.18 4/15/20232,580,000 shares $5.75 million -4.1%4.6%2.6 $2.23 3/31/20232,690,000 shares $5.73 million +66.1%5.1%2.2 $2.13 3/15/20231,620,000 shares $5.02 million +21.8%3.5%0.6 $3.10 2/28/20231,330,000 shares $3.92 million +16.7%2.9%0.5 $2.95 2/15/20231,140,000 shares $3.28 million -23.0%2.5%0.4 $2.88 1/31/20231,480,000 shares $4.08 million -20.0%3.1%0.5 $2.76 1/15/20231,850,000 shares $6.35 million -7.5%3.9%0.6 $3.43 12/30/20222,000,000 shares $7.40 million +102.0%4.2%0.8 $3.70 12/15/2022990,200 shares $1.64 million +0.1%1.7%0.4 $1.66 11/30/2022989,600 shares $1.22 million +44.3%1.7%1.3 $1.23 11/15/2022685,700 shares $654,980.64 -34.7%1.2%1 $0.96 10/31/20221,050,000 shares $971,355.00 -16.0%1.8%1.9 $0.93 10/15/20221,250,000 shares $1.11 million +131.4%2.2%2.6 $0.89 9/30/2022540,300 shares $401,983.20 +54.6%0.9%1.2 $0.74 9/15/2022349,600 shares $276,114.08 +1.7%0.6%0.9 $0.79He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here PRQR Short Interest - Frequently Asked Questions What is ProQR Therapeutics' current short interest? Short interest is the volume of ProQR Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 215,300 shares of PRQR short. 0.41% of ProQR Therapeutics' shares are currently sold short. Learn More on ProQR Therapeutics' current short interest. What is a good short interest ratio for ProQR Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PRQR shares currently have a short interest ratio of 1.0. Learn More on ProQR Therapeutics's short interest ratio. What is a good short interest percentage for ProQR Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.41% of ProQR Therapeutics' floating shares are currently sold short. Is ProQR Therapeutics' short interest increasing or decreasing? ProQR Therapeutics saw a decline in short interest in April. As of April 30th, there was short interest totaling 215,300 shares, a decline of 10.8% from the previous total of 241,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ProQR Therapeutics' float size? ProQR Therapeutics currently has issued a total of 81,360,000 shares. Some of ProQR Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ProQR Therapeutics currently has a public float of 51,890,000 shares. How does ProQR Therapeutics' short interest compare to its competitors? 0.41% of ProQR Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to ProQR Therapeutics: Gossamer Bio, Inc. (5.68%), Skye Bioscience, Inc. (0.29%), Seres Therapeutics, Inc. (14.17%), Prelude Therapeutics Incorporated (2.43%), Capricor Therapeutics Inc (13.14%), Incannex Healthcare Inc. (0.48%), CervoMed Inc. (1.06%), Greenwich LifeSciences, Inc. (3.24%), I-Mab (1.43%), scPharmaceuticals Inc. (17.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short ProQR Therapeutics stock? Short selling PRQR is an investing strategy that aims to generate trading profit from ProQR Therapeutics as its price is falling. PRQR shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ProQR Therapeutics? A short squeeze for ProQR Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PRQR, which in turn drives the price of the stock up even further. How often is ProQR Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRQR, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: GOSS Short Interest SKYE Short Interest MCRB Short Interest PRLD Short Interest CAPR Short Interest IXHL Short Interest CRVO Short Interest GLSI Short Interest IMAB Short Interest SCPH Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRQR) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsGold Set to EXPLODE!Gold Safe Exchange[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICElon to Transform U.S. Economy? Porter & Company